The 2019 first-quarter operational work meeting of Sinopharm Medical Devices was successfully held in Wuhan.

4 Month 22 Day, National Pharmaceutical Equipment 2019 The first-quarter operational work meeting of National Pharmaceutical Equipment was successfully held in Wuhan. Members of the party and government leadership team of National Pharmaceutical Equipment, heads of departments of the headquarters and scientific equipment business department, general managers and deputy general managers of regional business departments, general managers of various subsidiaries, and leaders in charge of operations and chief financial officers, totaling 570 people, participated in the meeting at the main venue in Wuhan and video sub-venues across the country. The meeting was chaired by Ms. Liu Yazhi, Deputy General Manager of National Pharmaceutical Equipment.

At the meeting, Mr. Yu Qingming, Party Secretary of Sinopharm Group, Chairman and Party Secretary of National Pharmaceutical Equipment, conveyed and studied the spirit of the “Two Sessions” based on his participation, and put forward requirements for 2019 year's key tasks. In his speech, Mr. Yu emphasized: We should continue the integration and consolidation of the equipment sector, give full play to professional advantages, and form a joint force for development. We should attach great importance to the achievement of various company budgets and management indicators, implement the various requirements of the Group's “Risk Control Year”, achieve process management, and follow up and implement them on a monthly and quarterly basis. We should pay close attention to the team building of all levels of leadership teams, cultivate professional talent teams, and lay a solid foundation for the future development of the company.

Combining the company's first-quarter operating situation, Mr. Li Yang, General Manager of National Pharmaceutical Equipment, made specific work deployments: First, attach great importance to the control of “two funds”. Strengthen the process management of “two funds”, making the management of “two funds” increasingly scientific and standardized. Second, establish and strengthen the awareness of red lines. From the functional departments of the headquarters to companies at all levels, it is necessary to have the ability to manage red lines and to establish the determination to realize the red line management goals. Third, strengthen the construction of provincial platforms. Provincial platforms should be built from two dimensions, namely performance and management. Second-level companies can only cope with the challenges brought about by the further sinking of the future network by continuously maintaining performance growth and constantly improving management levels. Fourth, continuously improve operational efficiency. To improve the company's operational efficiency, we must maintain a clear mind and a sense of crisis in order to stimulate continuous forward momentum, continuously improve efficiency, improve management, and control risks.

Ms. Tang Hua, Chief Financial Officer of National Pharmaceutical Equipment, made arrangements for 2019 year's key financial tasks, and Deputy General Manager Liu Yazhi deployed the “Beidou Plan” and related work of the “Risk Control Year”. Mr. Luo Shiqi, Minister of Risk and Operation Management Department, summarized and analyzed the company's first-quarter operating situation and reported the annual key tasks of risk and operation management.